Stallion India Fluorochemicals Limited — PPTs, 20-05-2025: Investor Presentation

1. Financial Highlights:

Stallion India Fluorochemicals posted revenue of INR 379.47 Cr for FY25, up significantly from INR 236.23 Cr in FY24. EBITDA rose to INR 49.74 Cr, with margin expansion to 13.11% from 11.37%. PAT, adjusting for a one-time provision of INR 10.71 Cr, doubled to INR 43.04 Cr, reflecting an 8.52% margin. Net worth strengthened to INR 300.84 Cr and cash balance rose to INR 75.01 Cr. Inventories and trade receivables built up to INR 100.84 Cr and INR 105.54 Cr, respectively.

2. Strategic Initiatives & Growth Drivers:

The firm is ramping up with two new facilities, including an HFO blending plant in Andhra Pradesh and specialty semiconductor gas capacity at Khalapur. Liquid helium processing capacity is scaling to 1,200 MT annually. Focus on eco-friendly HFO gases and backward integration aims at improving margins by 3-4%. Expansion targets high-growth segments like semiconductors, solar cells, and electronics.

3. Business Developments:

Product portfolio diversification continues with specialty gases across refrigerants, HFC/HFO blends, hydrocarbons, and non-refrigerants. The 2023 acquisition of Stallion Enterprises via slump sale boosts scale and market penetration. Forward integration efforts solidify operational capabilities.

4. Market Position & Competitive Advantage:

With ~10% share in India and over 200 clients across 15+ sectors, Stallion’s pan-India network of four operational and two upcoming plants supports scale advantages. Strengths include a robust distribution setup, stringent quality controls, and focus on higher-margin aftermarket customers. Strategic plant locations and agile supply chains underpin cost efficiency and responsiveness.

5. Investor Implications:

Strong double-digit top-line and profit growth, driven by capacity additions and specialty gas diversification, suggest positive growth potential. Healthy balance sheet and rising cash provide financial flexibility. Execution risks on new plant ramp-up and specialty segment expansion remain, but Stallion is well-positioned for sustainable margin gains in a growing fluorochemical market.